60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 681 | 254 | 511 | 6,353 |
| Cost of Goods | 385 | 475 | 432 | 851 |
| Gross Profit | 297 | -221 | 79 | 5,502 |
| Operating Expenses | 10,396 | 5,408 | 2,262 | 7,477 |
| Operating Income | -9,715 | -5,155 | -1,750 | -1,124 |
| Interest Expense | 8 | 2,287 | 3,989 | 3,173 |
| Other Income | 1,767 | 3,628 | -438 | 38 |
| Pre-tax Income | -7,955 | -3,814 | -6,177 | -4,259 |
| Income Tax | 0 | 0 | 1 | 1 |
| Net Income Continuous | -7,956 | -3,814 | -6,178 | -4,260 |
| Minority Interests | -9 | -48 | 4 | -9 |
| Net Income | $-7,947 | $-3,766 | $-6,182 | $-4,252 |
| EPS Basic Total Ops | -18.55 | -59.18 | -156.66 | N/A |
| EPS Basic Continuous Ops | -17.49 | -57.78 | -156.59 | N/A |
| EPS Diluted Total Ops | -18.55 | -59.18 | -156.66 | N/A |
| EPS Diluted Continuous Ops | -17.49 | -57.78 | -156.59 | N/A |
| EPS Diluted Before Non-Recurring Items | -18.55 | -123.65 | N/A | N/A |
| EBITDA(a) | $-6,075 | $-3,323 | $-507 | $-448 |